SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001356576-24-000067
Filing Date
2024-11-04
Accepted
2024-11-04 16:19:48
Documents
82
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q supn-20240930.htm   iXBRL 10-Q 1149530
2 EX-31.1 supn-20240930x10qxex311.htm EX-31.1 9660
3 EX-31.2 supn-20240930x10qxex312.htm EX-31.2 10022
4 EX-32.1 supn-20240930x10qxex321.htm EX-32.1 5152
5 EX-32.2 supn-20240930x10qxex322.htm EX-32.2 5169
11 LOGO supn-20240930_g1.jpg GRAPHIC 83658
  Complete submission text file 0001356576-24-000067.txt   6680575

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT supn-20240930.xsd EX-101.SCH 43028
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT supn-20240930_cal.xml EX-101.CAL 75518
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT supn-20240930_def.xml EX-101.DEF 166544
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT supn-20240930_lab.xml EX-101.LAB 593993
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT supn-20240930_pre.xml EX-101.PRE 399349
85 EXTRACTED XBRL INSTANCE DOCUMENT supn-20240930_htm.xml XML 963323
Mailing Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS, INC. (Filer) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35518 | Film No.: 241423858
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)